A. O. Smith sells 81% stake in China business to CPE

A. O. Smith agreed to sell an 81% interest in its China business to CPE at an approximately $400 million cash-free, debt-free valuation; including the net present value of multi-decade brand royalties, total value is expected to exceed $500 million. A. O. Smith will retain 19%, can repatriate approximately $80 million in China-held cash, and intends to prioritize share repurchases with after-tax proceeds and repatriated cash. The transaction is expected to close in the first half of 2027, subject to regulatory approvals and customary conditions.

Analysis

The key valuation question is not the headline transaction value but what earnings AOS gives up versus the cash it can actually redeploy. The royalty component is a long-dated estimate, not closing cash; investors should separate it from the sale proceeds and test the royalty rate, duration, minimum guarantees, and termination rights when disclosed. The 19% retained stake also leaves AOS exposed to China operating and regulatory outcomes, while licensing preserves brand exposure without full operating control.

Near term, the proposed buyback can support per-share results, but it does not by itself establish value creation: repurchases above intrinsic value, or purchases made before the earnings dilution from the disposal is clear, could offset that benefit. The deal is not expected to close until 1H27, leaving a long regulatory and execution window. Q3 results are the nearer catalyst: segment trends and any update to China earnings will help establish the earnings being sold and whether proceeds are incremental to the existing capital-return plan.

The contrarian risk is that a clean strategic exit is being read as an uncomplicated positive while investors lack the China business’s contribution, tax leakage, stranded-cost impact, and royalty economics. Conversely, the market may underweight reduced China competition and management distraction over time. No valuation conclusion is justified without those details; no direct read-through to Goldman Sachs’ fundamentals follows from its advisory role.

Key Decisions for Investors

• Do not chase AOS solely on the announced buyback. Reassess after Q3 results and the transaction filing clarify China earnings, tax-adjusted net cash proceeds, and the royalty formula.
• Treat AOS as a conditional long on weakness, not a confirmed event-driven trade: the upside case is disciplined repurchases plus lower operating exposure; the downside is disposal-related earnings dilution or repurchases that fail to earn an adequate return. Size only after comparing the transaction’s net proceeds with the earnings relinquished.
• Track 1H27 closing conditions and regulatory approvals as execution catalysts. Falsify the constructive thesis if closing slips materially, royalty protections prove weak, or management indicates a meaningful earnings/cost drag from the separation.
• At Q3, monitor China sales and operating contribution, full-year guidance, and the stated buyback authorization or pace. If the disposal reduces earnings more than cash-adjusted per-share value supports, avoid the long thesis; if proceeds are returned without weakening core investment, the capital-return case strengthens.